| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/03/1999 | US5932213 Modified plasmin precursors with resistance to inhibitors of plasmin |
| 08/03/1999 | US5932211 Glycosylation variants of iduronate 2-sulfatase |
| 08/03/1999 | US5932210 Partial or total deletion of the adenoviral protein ix dna and having a gene encoding a foreign protein or a functional fragment or mutant thereof. |
| 08/03/1999 | US5932209 Bacillus thuringiensis δ-endotoxin |
| 08/03/1999 | CA1340689C Human b-cell differentiation factor and process of producing said factor |
| 07/30/1999 | CA2246001A1 Novel compounds |
| 07/29/1999 | WO1999038014A1 Assessing risk for integrin antagonist/agonist mediated diseases |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037807A1 Method of isolation of rna-binding compounds |
| 07/29/1999 | WO1999037797A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | WO1999037790A1 Human calcineurin b-like protein |
| 07/29/1999 | WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | WO1999037786A2 Methods and compositions for modifying levels of secondary metabolic compounds in plants |
| 07/29/1999 | WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | WO1999037773A1 Acpl dna and polypeptides |
| 07/29/1999 | WO1999037769A1 Orphan receptors |
| 07/29/1999 | WO1999037765A1 Human vanilloid receptor homologues |
| 07/29/1999 | WO1999037763A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 07/29/1999 | WO1999037755A2 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 07/29/1999 | WO1999037753A1 Enzyme catalyzed therapeutic agents |
| 07/29/1999 | WO1999037752A1 Artificial cornea |
| 07/29/1999 | WO1999037751A1 Purified populations of stem cells |
| 07/29/1999 | WO1999037684A1 Antibodies to death receptor 4 (dr4) and uses thereof |
| 07/29/1999 | WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN |
| 07/29/1999 | WO1999037682A2 Antibodies against human il-12 |
| 07/29/1999 | WO1999037679A1 Ligand receptors and uses therefor |
| 07/29/1999 | WO1999037675A1 Nucleic acid sequences encoding capsaicin receptors |
| 07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | WO1999037662A1 Spoil protein and nucleic acid molecules and uses therefor |
| 07/29/1999 | WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | WO1999037333A1 Method for removing and/or inactivating viruses |
| 07/29/1999 | WO1999037332A1 Bone cancer therapy |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037313A1 Immune effector cell hybrids |
| 07/29/1999 | WO1999037147A1 Selection of mature sperm by surface membrane determinants |
| 07/29/1999 | WO1999037143A2 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 07/29/1999 | WO1999031219A3 Method for decomposing biological material |
| 07/29/1999 | WO1999025825A3 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 07/29/1999 | WO1999025396A3 Hybrid tissues for tissue engineering |
| 07/29/1999 | WO1999023231A3 Modification of the tocopherol content of transgenic plants |
| 07/29/1999 | WO1999019506A3 Method for identifying binding ligands to receptors |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | WO1998050530A3 Enzymatic nucleic acids: synthesis, selection and use |
| 07/29/1999 | DE19802375A1 Removal and/or inactivation of virus in blood products |
| 07/29/1999 | DE19801438A1 Use of phosphodiesterase (PDE) inhibitors to improve sperm motility in insemination and in-vitro fertilization procedures |
| 07/29/1999 | CA2319208A1 Orphan receptors |
| 07/29/1999 | CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin |
| 07/29/1999 | CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | CA2318987A1 Immune effector cell hybrids |
| 07/29/1999 | CA2318979A1 Antigen-specific cells, methods of generating these cells and uses thereof |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318816A1 Ligand receptors and uses therefor |
| 07/29/1999 | CA2318751A1 Method of isolation of rna-binding compounds |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318727A1 Spoil protein and nucleic acid molecules and uses therefor |
| 07/29/1999 | CA2318641A1 Artificial cornea |
| 07/29/1999 | CA2318405A1 Antibodies to death receptor 4(dr4) and uses thereof |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318070A1 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
| 07/29/1999 | CA2317704A1 Assessing risk for integrin antagonist/agonist mediated diseases |
| 07/29/1999 | CA2314246A1 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 07/29/1999 | CA2311729A1 Purified populations of stem cells |
| 07/28/1999 | EP0931830A2 Cytopathic viruses for therapy and phophylaxis of neoplasia |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931262A1 Biochemical markers of the human endometrium |
| 07/28/1999 | EP0931163A1 Assessment of intracellular cysteine and glutathione concentrations |
| 07/28/1999 | EP0931162A1 Production of a multimeric protein by cell fusion method |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931158A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| 07/28/1999 | EP0931157A1 Retroviral vectors |
| 07/28/1999 | EP0931155A1 Enhanced transgene expression in a population of monocot cells employing scaffold attachment regions |
| 07/28/1999 | EP0931150A2 Genetic control of fruit ripening |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | EP0931147A1 ANTI-ErbB2 ANTIBODIES |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0931143A1 Production of recombinant peptide by transgenic fish |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0930890A1 USE OF FasL OR FasL TRANSFECTED CD4?+ /FasL?- /TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES |
| 07/28/1999 | EP0930887A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 07/28/1999 | EP0698093B1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | EP0538401B1 Novel receptor-type phosphotyrosine phosphatase |
| 07/28/1999 | EP0131623B2 Chimeric genes suitable for expression in plant cells |
| 07/28/1999 | CN1224465A Use of interleukin-10 to produce population of suppressor cells |
| 07/28/1999 | CN1224464A Growth factor and genetic sequence encoding same |
| 07/28/1999 | CN1224461A Use of stem cell factor and soluble interleukin-6 receptor for ex vivo expansion of hematopoietic multipotential cells |
| 07/28/1999 | CN1224460A Cell compositions |
| 07/28/1999 | CN1224428A Cellular injury response element and uses thereof |
| 07/28/1999 | CN1044384C Construction of anti-hepatitis C virus antigen monoclonal antibody cell strain and monoclonal antibody thereof |
| 07/28/1999 | CA2260482A1 Method for enrichment of fetal cells from maternal blood and use of same in determination of fetal sex and detection of chromosomal abnormalities |
| 07/27/1999 | US5929307 Method for the production of hybrid plants |
| 07/27/1999 | US5929302 Plant transformed with chimeric gene conferring fungal resistance |
| 07/27/1999 | US5929224 Dna encoding human white blood cell activating proteins; useful in diagnosis as anticarcinogenic agents |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5929210 Purified polypeptide of irreversible, extracellular serine protease inhibitor; for diagnosis/treatment of related diseases; antitumor agents; cushing's/alzheimer's/parkinson's diseases; dwarfism; eating disorders |